FIGURE 1.

A–C, Extracorporeal life support (ECLS) circuit configuration, indication, and anticoagulation strategy. *measured in higher or reduced prothrombin time (PTT) or **activated clotting time (ACT); ***were specified as direct thrombin inhibition (n = 1) and Anti‐Xa‐activity (n = 1). (D,E) Duration of ECLS therapy and reasons for treatment discontinuation. *were specified as futility (n = 2), intractable septic shock (n = 1), multi‐organ failure (n = 3), and bleeding other than intracranial (n = 1)